4.8 Article

Induction of amphiregulin by p53 promotes apoptosis via control of microRNA biogenesis in response to DNA damage

出版社

NATL ACAD SCIENCES
DOI: 10.1073/pnas.1313675111

关键词

microarray; Drosha; miRNA processing

资金

  1. Ministry of Education, Science and Culture of Japan
  2. Jikei University Graduate Research Fund
  3. NOVARTIS Foundation for the Promotion of Science
  4. Suzuken Memorial Foundation
  5. Uehara Memorial Foundation
  6. Astellas Foundation for Research on Medical Resources
  7. Takeda Science Foundation
  8. Mochida Memorial Foundation for Medical and Pharmaceutical Research
  9. Sumitomo Foundation
  10. Naito Foundation
  11. Japan Foundation for Applied Enzymology
  12. Project Mirai Cancer Research Grants
  13. Yasuda Memorial Foundation
  14. Japan Society for the Promotion of Science
  15. Nakajima Foundation
  16. Grants-in-Aid for Scientific Research [26290041, 25640080, 23300347] Funding Source: KAKEN

向作者/读者索取更多资源

Upon DNA damage, tumor suppressor p53 determines cell fate by repairing DNA lesions to survive or by inducing apoptosis to eliminate damaged cells. The decision is based on its posttranslational modifications. Especially, p53 phosphorylation at Ser46 exerts apoptotic cell death. However, little is known about the precise mechanism of p53 phosphorylation on the induction of apoptosis. Here, we show that amphiregulin (AREG) is identified for a direct target of Ser46 phosphorylation via the comprehensive expression analyses. Ser46-phosphorylated p53 selectively binds to the promoter region of AREG gene, indicating that the p53 modification changes target genes by altering its binding affinity to the promoter. Although AREG belongs to a family of the epidermal growth factor, it also emerges in the nucleus under DNA damage. To clarify nuclear function of AREG, we analyze AREG-binding proteins by mass spectrometry. AREG interacts with DEAD-box RNA helicase p68 (DDX5). Intriguingly, AREG regulates precursor microRNA processing (i.e., miR-15a) with DDX5 to reduce the expression of antiapoptotic protein Bcl-2. These findings collectively support a mechanism in which the induction of AREG by Ser46-phosphorylated p53 is required for the microRNA biogenesis in the apoptotic response to DNA damage.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Enforced dual-specificity tyrosine-regulated kinase 2 expression by adenovirus-mediated gene transfer inhibits tumor growth and metastasis of colorectal cancer

Yuta Imaizumi, Saishu Yoshida, Yumi Kanegae, Ken Eto, Kiyotsugu Yoshida

Summary: In colorectal cancer, the expression of DYRK2 is decreased, affecting clinical prognosis. Overexpression of DYRK2 through adenovirus-mediated gene transfer can inhibit cell proliferation and induce apoptosis, providing a potential therapy for colorectal cancer.

CANCER SCIENCE (2022)

Review Gastroenterology & Hepatology

Multiple subcellular localizations and functions of protein kinase Cδ in liver cancer

Kohji Yamada, Kiyotsugu Yoshida

Summary: Protein kinase C delta (PKC delta) is a member of the PKC family and plays important roles in various biological and cancerous processes. Its function is regulated by factors such as phosphorylation and subcellular localization. Recent studies have found its unique extracellular localization and growth factor-like function in liver cancer cells, contributing to our understanding of its involvement in liver cancer progression.

WORLD JOURNAL OF GASTROENTEROLOGY (2022)

Article Oncology

Extracellular PKC delta signals to epidermal growth factor receptor for tumor proliferation in liver cancer cells

Kohji Yamada, Ryusuke Kizawa, Ayano Yoshida, Rei Koizumi, Saya Motohashi, Yuya Shimoyama, Yoshito Hannya, Saishu Yoshida, Tsunekazu Oikawa, Masayuki Shimoda, Kiyotsugu Yoshida

Summary: PKC delta is secreted from liver cancer cells and binds to the epidermal growth factor receptor (EGFR), activating the EGFR signaling pathway and promoting cell proliferation and tumor growth in liver cancer.

CANCER SCIENCE (2022)

Article Cell Biology

DYRK2 maintains genome stability via neddylation of cullins in response to DNA damage

Akira Kawamura, Saishu Yoshida, Katsuhiko Aoki, Yuya Shimoyama, Kohji Yamada, Kiyotsugu Yoshida

Summary: This study reveals that dual-specificity tyrosine-regulated kinase 2 (DYRK2) is a novel regulator of neddylation, promoting neddylation through forming a complex with NEDD8-activating enzyme E1 component NAE1, and thus maintaining genome stability.

JOURNAL OF CELL SCIENCE (2022)

Article Multidisciplinary Sciences

Extended-synaptotagmin 1 engages in unconventional protein secretion mediated via SEC22B+ vesicle pathway in liver cancer

Kohji Yamada, Saya Motohashi, Tsunekazu Oikawa, Naoko Tago, Rei Koizumi, Masaya Ono, Toshiaki Tachibana, Ayano Yoshida, Saishu Yoshida, Masayuki Shimoda, Masahiro Oka, Yoshihiro Yoneda, Kiyotsugu Yoshida

Summary: The study reveals the role of E-Syt1 in mediating cytosolic protein secretion at the ER-PM contact sites in liver cancer cells. SEC22B vesicles tethered to the PM via Q-SNAREs for their secretion, while PKC delta secretion and tumorigenicity were regulated by the interaction with E-Syt1.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Oncology

Inhibition of protein kinase C delta leads to cellular senescence to induce anti-tumor effects in colorectal cancer

Yuya Shimoyama, Kohji Yamada, Saishu Yoshida, Akira Kawamura, Yoshito Hannya, Yuta Imaizumi, Tomotaka Kumamoto, Yasuhiro Takeda, Masayuki Shimoda, Ken Eto, Kiyotsugu Yoshida

Summary: This study investigates the role of PKC delta in colorectal cancer (CRC) and finds that PKC delta acts as a negative regulator of cellular senescence in p53 wild-type CRC. The activation of p21 via a p53-independent pathway by PKC delta is shown to be essential for its activity. The study also proposes a novel therapeutic strategy for CRC targeting wt-p53.

CANCER SCIENCE (2023)

Article Biochemistry & Molecular Biology

Cancer-Related Unconventional Protein Secretion: A New Role of the Endoplasmic Reticulum

Kohji Yamada, Kiyotsugu Yoshida

Summary: Unconventional protein secretion (UPS) is a crucial mechanism controlling the localization of cytosolic proteins lacking signal peptides and is implicated in inflammation, neurodegenerative diseases, and cancer. This article provides an overview of UPS mechanisms and categorizes cancer-specific UPS as CUPS due to their distinct features in cancer cells.

DNA AND CELL BIOLOGY (2023)

Article Biochemistry & Molecular Biology

Extended-Synaptotagmin 1 Enhances Liver Cancer Progression Mediated by the Unconventional Secretion of Cytosolic Proteins

Kohji Yamada, Yoshito Hannya, Tsunekazu Oikawa, Ayano Yoshida, Kuniko Katagiri, Saishu Yoshida, Rei Koizumi, Naoko Tago, Yuya Shimoyama, Akira Kawamura, Yuta Mochimaru, Ken Eto, Kiyotsugu Yoshida

Summary: This study demonstrates that E-Syt1 plays a critical role in the tumorigenic potential of liver cancer cells. E-Syt1 depletion inhibits cell proliferation and is associated with a poorer prognosis in hepatocellular carcinoma. Furthermore, E-Syt1 is required for the unconventional secretion of PKCd and the activation of IGF1R and Erk1/2 signaling pathways, which are implicated in liver cancer tumorigenesis.

MOLECULES (2023)

Review Biochemistry & Molecular Biology

New insights into the roles for DYRK family in mammalian development and congenital diseases

Saishu Yoshida, Kiyotsugu Yoshida

Summary: The DYRK family, from invertebrates to mammals, plays a crucial role in regulating cell processes such as proliferation, apoptosis, survival, and differentiation. However, limited evidence exists regarding their in vivo roles in mammalian development. This review provides an overview of in vivo studies on Dyrks, shedding light on their roles in mammalian tissue development and congenital diseases.

GENES & DISEASES (2023)

Article Oncology

DYRK2 promotes chemosensitivity via p53-mediated apoptosis after DNA damage in colorectal cancer

Yasuhiro Takano, Satomi Yogosawa, Yuta Imaizumi, Hiroshi Kamioka, Yumi Kanegae, Ken Eto, Kiyotsugu Yoshida

Summary: DYRK2 expression is associated with chemosensitivity to 5-fluorouracil and oxaliplatin in p53 wild-type colorectal cancer, suggesting its importance as a new marker in therapeutic strategies.

CANCER SCIENCE (2023)

Article Gastroenterology & Hepatology

Dyrk2 gene transfer suppresses hepatocarcinogenesis by promoting the degradation of Myc and Hras

Hiroshi Kamioka, Satomi Yogosawa, Tsunekazu Oikawa, Daisuke Aizawa, Kaoru Ueda, Chisato Saeki, Koichiro Haruki, Masayuki Shimoda, Toru Ikegami, Yuji Nishikawa, Masayuki Saruta, Kiyotsugu Yoshida

Summary: DYRK2 has been found to play an anti-tumor role in hepatocellular carcinoma (HCC) by promoting the degradation of Myc and Hras. This study provides new insights into the potential therapeutic approach of using DYRK2 gene transfer for HCC treatment.

JHEP REPORTS (2023)

Review Biochemistry & Molecular Biology

Functional Roles of DYRK2 as a Tumor Regulator

Yuta Mochimaru, Kiyotsugu Yoshida

Summary: DYRK2 plays diverse roles in cancer, with controversy regarding its functional conservation. Although studies have been conducted in different types of cancer, the current methods used are not sufficient to fully comprehend the role of DYRK2 in cancer.

CURRENT ISSUES IN MOLECULAR BIOLOGY (2023)

Meeting Abstract Oncology

Extracellular localization of PKCδ and its function as a growth factor to activate ERK signaling in liver cancer

Kohji Yamada, Tsunekazu Oikawa, Saya Motohashi, Ayano Yoshida, Rei Koizumi, Saishu Yoshida, Kiyotsugu Yoshida

CANCER SCIENCE (2022)

Meeting Abstract Oncology

New Secretion System of Intracellular KinasePKCδ is unconventionally secreted in liver cancer cells

Saya Motohashi, Kohji Yamada, Ayano Yoshida, Rei Koizumi, Kiyotsugu Yoshida

CANCER SCIENCE (2022)

暂无数据